Endoscopy Practice and Sedation: Sedation Depth and Agents

0:00Welcome to Board Pearls. This is episode two of four of the Endoscopy Practice and Sedation chapter, in the Endoscopic Procedures module. In this episode we cover the depth-and-agent half of procedural sedation: the sedation continuum and ASA physical status that decide who needs anesthesia, midazolam plus fentanyl for the routine case versus propofol for the complex one, and the alternative agents, etomidate, ketamine, and dexmedetomidine, that handle the situations the standard pair cannot.

0:30Procedural sedation has one organizing trade. The depth you want is the depth that lets you do the procedure with the patient comfortable and unaware, and the depth you can afford is the depth your team can rescue from. Those two depths are not always the same. Every other decision in this chapter reduces to fixing the gap. The agent choice, the personnel, the monitoring, the rescue drugs, and the population-specific tweaks all serve the same purpose: closing the distance between intended depth and the depth at which the patient actually arrives.

1:05Start with the ASA continuum because the language is precise and the boards test it precisely. Minimal sedation is anxiolysis. The patient answers normally, breathes normally, and protects the airway. Moderate sedation, the old conscious sedation, is a purposeful response to verbal commands, alone or with light tactile prompting. Reflex withdrawal from a painful stimulus does not count as purposeful. Deep sedation requires repeated or painful stimulation to elicit a response, and the airway may need support. General anesthesia is unarousable and frequently needs positive-pressure ventilation. The clinical implication of the continuum is the rescue rule. The practitioner must be qualified to manage a patient one level deeper than the intended target. Individual response is variable, and a moderate-sedation plan reliably drifts into deep sedation in a subset of patients.

1:58ASA physical status frames who is safe at what depth. Class one is a healthy patient. Class two is mild systemic disease, controlled hypertension, well-controlled diabetes, mild obesity, a current smoker, mild COPD. Class three is severe systemic disease, poorly controlled hypertension or diabetes, BMI over forty, stable angina. Class four is severe disease that constantly threatens life, recent myocardial infarction, unstable angina, end-stage renal disease on dialysis. Class five is moribund and class six is brain-dead for organ donation. The rule that matters at the bedside is straightforward. ASA class one and two patients tolerate endoscopist-supervised moderate sedation with midazolam and fentanyl for routine EGD and colonoscopy. ASA class three and above warrants anesthesia involvement, both because cardiopulmonary complication rates rise stepwise across the strata and because the complex procedures these patients tend to need favor propofol over a benzodiazepine-opioid combination.

3:08The midazolam-plus-fentanyl regimen is the mainstay for the easy case, and the pharmacology explains why. Midazolam potentiates GABA-A receptors and produces dose-dependent anxiolysis with anterograde amnesia. The amnesia is therapeutically useful because procedural recall corrodes tolerance for repeat endoscopy. Dosing is zero point five to two milligrams intravenous initial bolus, titrated in one milligram increments every two to five minutes, with peak effect at three to five minutes. Total dose in a healthy adult typically runs two to five milligrams. Fentanyl provides the analgesia at twenty-five to one hundred micrograms initial bolus, with twenty-five to fifty microgram increments, peak at three to five minutes, and a duration of thirty to sixty minutes. Fentanyl is preferred over morphine because the onset is faster, the duration is shorter, and histamine release is minimal, which means less hypotension and less pruritus.

4:04The synergy between benzodiazepine and opioid is the whole point of the combination and also its dominant safety risk. Respiratory depression is multiplicative rather than additive when the two classes are given together. The clinical translation of that pharmacology is the titration rhythm. Small increments. Wait for peak effect before redosing. Watch ventilation continuously rather than intermittently. And it is the reason capnography matters here more than the pulse oximeter.

4:35Propofol takes over when the procedure is long, when the procedure is complex, when the patient is ASA class three or above, or when aspiration risk is elevated. The pharmacokinetics are what make it ideal. Onset within thirty to forty seconds. A short context-sensitive half-time, which means the time to half-recovery after stopping a continuous infusion stays short even after long infusions, because redistribution from central to peripheral compartments and rapid hepatic glucuronidation drive offset. Induction is zero point five to one milligram per kilogram, followed by intermittent ten to twenty milligram boluses or a continuous infusion at roughly twenty-five to one hundred micrograms per kilogram per minute. The mechanism is GABA-A potentiation through a different binding site than the benzodiazepines.

5:24The trade-off is the part that drives staffing. Propofol has no antagonist. Apnea and loss of airway protective reflexes happen predictably at therapeutic doses and must be managed actively rather than reversed. That is why airway-trained personnel must be immediately available when propofol is used, and why monitored anesthesia care is the typical service designation for propofol-based sedation in the more complex cases. Propofol also drops systemic vascular resistance and produces dose-dependent hypotension, which is why it is titrated cautiously in the hypovolemic patient, the cirrhotic patient, and the patient with fixed cardiac output. The ASGE and ASA position is that propofol-based moderate-to-deep sedation in healthy patients can be administered by trained endoscopist-led teams with appropriate monitoring. ASA class three and above warrants anesthesia involvement. So do the complex procedures, ERCP, EUS, ESD, and deep enteroscopy.

6:22A few alternative agents handle specific situations the standard pair cannot. Etomidate at zero point one to zero point two milligrams per kilogram is the induction agent for the hemodynamically unstable patient because it preserves blood pressure and cardiac output with minimal vasodilation. The cost is adrenal suppression. A single dose suppresses cortisol production for six to twenty-four hours through inhibition of eleven-beta-hydroxylase. The clinical consequence is that etomidate is avoided in the septic patient, where the adrenal axis is already stressed and a transient suppression matters. The classic stem is the patient with active hemorrhage and severe aortic stenosis who needs emergent endoscopy. Propofol drops the afterload and the fixed valve cannot compensate. Ketamine raises the heart rate and shortens diastolic filling. Etomidate is the answer.

7:11Ketamine produces dissociative anesthesia through NMDA antagonism and preserves respiratory drive and airway tone. It is useful when propofol-induced apnea is unacceptable, and when an opioid-tolerant patient needs analgesia. The cost is sympathomimetic effect, raised blood pressure and heart rate and intracranial pressure, plus emergence reactions in adults that benzodiazepines mitigate. The case where ketamine wins is the uncooperative patient without intravenous access, because intramuscular dosing is feasible.

7:40Dexmedetomidine is an alpha-two agonist that produces sedation without respiratory depression. It is the opioid-sparing choice when airway maintenance is critical, severe OSA, achalasia. The limitations are slow onset and bradycardia, which keep it out of routine endoscopy.

7:59So the depth-and-agent logic comes down to matching the drug to the gap between intended depth and rescue capability. ASA physical status predicts who tolerates endoscopist-supervised moderate sedation and who needs anesthesia, with class one and two carried by midazolam and fentanyl and class three and above shifted toward propofol. The benzodiazepine-opioid pair buys amnesia and analgesia at the cost of multiplicative respiratory depression, so it is titrated in small increments to peak effect. Propofol buys fast onset and fast offset for the long or complex case at the cost of having no antagonist, which is why airway-trained personnel come with it. And the alternative agents each solve one problem the pair cannot: etomidate preserves hemodynamics in the unstable patient, ketamine preserves respiratory drive and airway tone, and dexmedetomidine sedates without respiratory depression when the airway is precarious.

8:58The next episode takes the safety apparatus that sits on top of the agents: capnography catching apnea before the pulse oximeter desaturates, the airway predictors that decide whether the standard plan is safe before the first dose, the flumazenil and naloxone reversals, the special-population modifications from cirrhosis to pregnancy, and the updated GLP-1 periprocedural guidance.

9:20For the full chapter, the practice vignettes, and the topic-tagged question bank, head to board pearls dot com. You'll find the rest of the series on Apple Podcasts, Spotify, or wherever you listen to podcasts. That brings us to the end of episode two of four of chapter twenty eight, and I'll see you in the next one.